Suspected pneumonic plague in Siberia: What we know about the disease

SHELEKHOV, IRKUTSK OBLAST, RUSSIA, 5 OCTOBER 2026 —

The death of a 28-year-old laboratory worker in Siberia has triggered a significant public health response, with Russian authorities placing nearly 200 individuals under medical observation following suspected exposure to a plague pathogen.

The worker died on Friday, October 2, 2026, at a district hospital in Shelekhov, a town near Irkutsk, after local media reported she had dropped a test tube during her duties.

Russian officials have issued conflicting accounts regarding the cause of death. According to Interfax news agency, citing Rospotrebnadzor, Russia’s disease-control agency, the woman died of "pneumonia of unknown origin." The agency stated that samples taken from the deceased showed no microorganisms "related to her professional activities," a claim that contradicts earlier reports suggesting a link to her work at the plague research institute.

Despite these official statements, the scale of the quarantine measures suggests a serious internal assessment of potential exposure. Two hospitals and a children’s clinic were placed under quarantine, while local reports indicated that staff at the institute were being isolated at their workplace.

The US news site Axios reported that approximately 200 people who had been in contact with the worker were placed under observation, though no further infections have been reported as of the latest updates.

The incident has reignited distrust regarding how Russia handles public health information. On one of DW’s Russian-language social media channels, a user commented on the potential for the situation to escalate, writing: "It wouldn't surprise me if this turns into a disaster now, both in terms of the spread and the quarantine measures." This skepticism persists despite the absence of confirmed secondary cases.

The primary concern among health experts and observers is the nature of the pathogen involved, specifically pneumonic plague, which is distinct from other forms of the disease due to its high contagion rate and rapid progression.

Pneumonic plague is caused by the bacterium Yersinia pestis, which is typically found in small mammals such as rodents and the fleas that feed on them. The World Health Organization (WHO) describes the pneumonic form as the most virulent type of plague. Unlike bubonic plague, which is the most common form and usually follows a flea bite, pneumonic plague infects the lungs directly.

It is the only form of plague that passes easily from person to person through respiratory particles released when a sick patient coughs. This mode of transmission is why the WHO warns that it can trigger severe epidemics if not contained quickly.

The clinical presentation of pneumonic plague is rapid and severe. Symptoms appear quickly, including high fever, headache, and weakness, followed by a rapidly worsening pneumonia characterized by shortness of breath, chest pain, and a cough that often brings up blood. The incubation period can be as short as 24 hours.

A person can contract the disease by breathing in the bacteria directly or by developing it when untreated bubonic or septicemic plague spreads to the lungs. The distinction between the three forms of plague—bubonic, septicemic, and pneumonic—lies in where the infection settles in the body, which dictates how the disease spreads and its lethality.

Untreated, the mortality rates for these forms are stark. Bubonic plague kills between 30% and 60% of patients, while septicemic and pneumonic forms are always fatal without treatment. The septicemic form, which occurs when bacteria enter the bloodstream, causes bleeding under the skin, tissue death in the fingers and toes, and organ failure. However, pneumonic plague is curable if treatment begins promptly.

The WHO warns that without intervention, the disease can kill within 18 to 24 hours of the first symptoms appearing. Speed is the critical factor in determining the outcome, with high recovery rates observed when patients are treated within about a day of falling ill.

Medical protocols for pneumonic plague emphasize immediate action. The US Centers for Disease Control and Prevention (CDC) advises doctors not to wait for laboratory confirmation and to start antibiotics as soon as plague is suspected. The drugs used are standard, widely available antibiotics, not rare or specialized compounds. Patients typically require a course of treatment lasting up to two weeks.

To prevent further spread, patients are kept in isolation, and the use of masks is recommended to protect those around them, according to the WHO.

Preventive measures are also strictly defined for those exposed to the disease. Both the WHO and the CDC recommend a seven-day course of preventive antibiotics for close contacts of anyone with pneumonic plague, even if they show no symptoms. Regarding long-term protection, the WHO does not recommend a plague vaccine for the general public.

Instead, vaccination is reserved for high-risk groups, such as laboratory staff who work directly with the bacterium and health workers involved in outbreak response. The current situation in Siberia highlights the critical importance of these protocols, as the initial exposure occurred in a high-risk professional setting where such preventive measures are standard practice.